1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline has been researched along with Drug Withdrawal Symptoms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Kamińska, A; Lenda, T; Lorenc-Koci, E; Rommelspacher, H; Schulze, G; Smiałowska, M; Wierońska, J; Zieba, B | 1 |
1 other study(ies) available for 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electromyography; Male; Mitochondria, Muscle; Motor Activity; Muscle, Skeletal; Neural Pathways; Neurons; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Substantia Nigra; Tetrahydroisoquinolines; Time Factors; Tissue Distribution; Tyrosine 3-Monooxygenase | 2008 |